Stock 7779 CYBERDYNE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company CYBERDYNE Inc.

Equities

7779

JP3311530004

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-24 am EDT 		5-day change 1st Jan Change
208 JPY -1.42% Intraday chart for CYBERDYNE Inc. +5.05% -7.14%
Feb. 15 CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization CI
2023 Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings MT

Business Summary

Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.

Number of employees: 257

Sales per Business

JPY in Million2022Weight2023Weight Delta
Robot
100.0 %
2,150 100.0 % 3,289 100.0 % +52.98%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
47.0 %
1,496 69.5 % 1,547 47.0 % +3.41%
Americas
33.5 %
245 11.4 % 1,102 33.5 % +349.80%
APAC
11.2 %
219 10.2 % 370 11.2 % +68.95%
EMEA
8.2 %
191 8.9 % 271 8.2 % +41.88%

Managers

Managers TitleAgeSince
Yoshiyuki Sankai FOU
 Founder 65 04-06-23
Shinji Uga DFI
 Director of Finance/CFO 54 08-08-31
Shinji Honda COO
 Chief Operating Officer 65 Dec. 17
Yoshihiro Yasunaga BRD
 Director/Board Member 49 08-03-31
Jaroslaw Jacek Walukiewicz PRN
 Corporate Officer/Principal - 13-12-31

Members of the board

Members of the board TitleAgeSince
Kazumasa Yoshida BRD
 Director/Board Member 65 13-05-31
Shinji Honda COO
 Chief Operating Officer 65 Dec. 17
Hikari Imai BRD
 Director/Board Member 74 15-05-31
Yoshiyuki Sankai FOU
 Founder 65 04-06-23
Shinji Uga DFI
 Director of Finance/CFO 54 08-08-31
Hiroaki Kawamoto BRD
 Director/Board Member 49 04-06-23
Kinichi Nakata BRD
 Director/Board Member 61 08-05-31
Yoshihiro Yasunaga BRD
 Director/Board Member 49 08-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 77,700,000 0 0 46.92 %
Stock B 0 137,445,809 100,953,436 ( 73.45 %) 4,014,573 ( 2.921 %)

Shareholders

NameEquities%Valuation
DAIWA HOUSE INDUSTRY CO., LTD.
18.92 %
26,000,000 18.92 % 37 M ¥
CYBERDYNE INC.
2.921 %
4,014,500 2.921 % 6 M ¥
Yoshiyuki Sankai
2.213 %
3,042,000 2.213 % 4 M ¥
Martin Currie Asia Pte Ltd.
1.455 %
2,000,000 1.455 % 3 M ¥
Sawakami Asset Management, Inc.
1.230 %
1,690,000 1.230 % 2 M ¥
Mikio Yano
0.6085 %
836,400 0.6085 % 1 M ¥
T&D HOLDINGS INC.
0.3638 %
500,000 0.3638 % 703 690 ¥
Hidenaga Ishii
0.3342 %
459,300 0.3342 % 646 410 ¥
TSUKUBA BANK, LTD.
0.1746 %
240,000 0.1746 % 337 771 ¥
Ichiyoshi Asset Management Co., Ltd.
0.0728 %
100,000 0.0728 % 140 738 ¥
NameEquities%Valuation
Yoshiyuki Sankai
100.00 %
77,700,000 100.00 % 109 M ¥

Holdings

NameEquities%Valuation
CYBERDYNE INC.
2.92%
 4,014,500 2.92% 5,649,927 $
CYFUSE BIOMEDICAL K.K.
2.95%
 233,300 2.95% 1,123,762 $
KRINGLE PHARMA, INC.
3.18%
 200,000 3.18% 696,422 $

Company contact information

CYBERDYNE, Inc.

2-2-1 Gakuen Minami

305-0818, Tsukuba

+81 29 855 3189

http://www.cyberdyne.jp
address CYBERDYNE Inc.(7779)

Sector

Healthcare
Healthcare Services
Healthcare Providers & Services
Healthcare Facilities & Services
Other Healthcare Facilities & Services

Sales per region

Ratings for CYBERDYNE Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
211 JPY
Average target price
320 JPY
Spread / Average Target
+51.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CYBERDYNE INC. Stock CYBERDYNE Inc.
-7.14% 288M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-13.25% 86.34B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+18.01% 84.49B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+11.97% 29.68B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-8.50% 17.5B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.96% 16.67B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.14% 12.71B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.21% 12.53B
PURE HEALTH HOLDING Stock Pure Health Holding
-30.70% 11.89B
DAVITA INC. Stock DaVita Inc.
+27.83% 11.74B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 7779 Stock
  4. Company CYBERDYNE Inc.